Artwork

Content provided by Z3 News and James Bailey. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Z3 News and James Bailey or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

David Martin presents hard evidence showing COVID-19 is a man-made bioweapon.

1:34:47
 
Share
 

Manage episode 285229858 series 1314413
Content provided by Z3 News and James Bailey. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Z3 News and James Bailey or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
David E. Martin PhD is the developer of several innovation-based quantitative indices of public equities and founder of the Purple Bridge Funds and M-CAM International. He has worked closely with the United States Congress and numerous trade and financial regulatory agencies in the United States. Dr. Martin is also a Batten Fellow at the University of Virginia's Darden Graduate School of Business Administration. Since 1999, Dr. Martin has been actively tracking patent applications and approvals for the purpose of identifying suspicious activity. In the 94-minute video shown below, he shares the findings from his research regarding the laboratory development of a pathogenic coronavirus that started in 1999 and released initially upon human populations in the SARS CoV-1 in 2002-2003, then again in MERS (Middle East Respiratory Syndrome in 2012, and then again in SARS CoV-2 which was renamed COVID-19, as shown below with evidence from the primary development lab in Wuhan China. In my opinion, his research proves that all of these pathogenic variants of the coronavirus were laboratory developed, man-made bioweapons. And they've all been funded by the NIAID under the direction of a self-proclaimed Jesuit, Dr. Anthony Fauci.
  continue reading

148 episodes

Artwork
iconShare
 
Manage episode 285229858 series 1314413
Content provided by Z3 News and James Bailey. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Z3 News and James Bailey or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
David E. Martin PhD is the developer of several innovation-based quantitative indices of public equities and founder of the Purple Bridge Funds and M-CAM International. He has worked closely with the United States Congress and numerous trade and financial regulatory agencies in the United States. Dr. Martin is also a Batten Fellow at the University of Virginia's Darden Graduate School of Business Administration. Since 1999, Dr. Martin has been actively tracking patent applications and approvals for the purpose of identifying suspicious activity. In the 94-minute video shown below, he shares the findings from his research regarding the laboratory development of a pathogenic coronavirus that started in 1999 and released initially upon human populations in the SARS CoV-1 in 2002-2003, then again in MERS (Middle East Respiratory Syndrome in 2012, and then again in SARS CoV-2 which was renamed COVID-19, as shown below with evidence from the primary development lab in Wuhan China. In my opinion, his research proves that all of these pathogenic variants of the coronavirus were laboratory developed, man-made bioweapons. And they've all been funded by the NIAID under the direction of a self-proclaimed Jesuit, Dr. Anthony Fauci.
  continue reading

148 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide